首页> 外国专利> Composition for preventing improving or treating hepatic fibrosis or liver cirrhosis comprising Aster tataricus Linne fil extract

Composition for preventing improving or treating hepatic fibrosis or liver cirrhosis comprising Aster tataricus Linne fil extract

机译:预防或改善肝纤维化或肝硬化的组合物,其包含紫ster提取物

摘要

The present invention relates to a composition for preventing, alleviating or treating liver fibrosis or liver cirrhosis, which comprises an Aster tataricus Linne fil extract as an effective component, wherein the composition exhibits excellent hepatoprotective effects through increased apoptosis, collagen reduction, and ECM accumulation reduction in HSC-T6 cell lines and hepatic stellate cells. Additionally, the composition of the present invention exhibits excellent anti-fibroblastic effects by improving serum AST and ALT in an animal model of TAA-induced liver cirrhosis; restoring the total GSH level to a normal level; and down-regulating the expressions of TGF-, -SMA and Col1a2, which are genes related to hydroxyproline level reduction and liver fibrosis. Accordingly, the composition of the present invention may be beneficially used as an agent for improving liver functions or treating liver fibrosis or liver cirrhosis.
机译:本发明涉及用于预防,减轻或治疗肝纤维化或肝硬化的组合物,其包含紫tLinne fil提取物作为有效成分,其中该组合物通过增加细胞凋亡,减少胶原蛋白和减少ECM积聚表现出优异的保肝作用。在HSC-T6细胞系和肝星状细胞中另外,本发明的组合物通过改善TAA诱导的肝硬化动物模型中的血清AST和ALT表现出优异的抗成纤维细胞作用。将总谷胱甘肽水平恢复到正常水平;并下调与羟脯氨酸水平降低和肝纤维化有关的基因TGF-,-SMA和Col1a2的表达。因此,本发明的组合物可以有利地用作改善肝功能或治疗肝纤维化或肝硬化的试剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号